Universal Health Services Inc

UHS remains in a Stage 4 decline with rallies stalling at declining EMAs despite the recent Lockout Rally. Medium-term bias stays bearish and current price is pulling back into the EMA cluster, presenting a tactical opportunity to trim into strength around the 9/21/50 EMA zone. We will defer selling until price rallies into resistance and shows rejection. A decisive close above the EMAs with follow-through would invalidate the bearish posture.

• ↑Q1 2026 revenue $4.50B (+9.6% YoY); behavioral health up 7.3% same-facility
• ↑Adjusted EPS $5.65 (+16.1% YoY); FY2026 EPS growth projected at 8%
• ↓One Beautiful Bill Act may cut Medicaid benefits ~$360–400M